Hengeler Mueller advises Elanco Animal Health on Bayer Animal Health Acquisition
20. August 2019
Elanco Animal Health Incorporated today announced it had entered into an agreement with Bayer AG to acquire its animal health business in a transaction valued at $7.6 billion. The transaction will be financed by a 70% cash/30% equity combination.
Hengeler Mueller advises Elanco on the acquisition together with Paul, Weiss, Rifkind, Wharton & Garrison LLP (team is led by Tarun Stewart, New York). The Hengeler Mueller team is led by partners Christian Möller and Maximilian Schiessl (both M&A, Düsseldorf) and includes partners Hendrik Bockenheimer (Employment, Frankfurt), Wolfgang Kellenter (IP, Düsseldorf), Matthias Scheifele (Tax, München) and Dirk Uwer (Life Sciences / Public Law, Düsseldorf), counsel Markus Ernst (Tax, München), Benedikt Migdal (IP, Düsseldorf), Eckbert Müller (Employment, Frankfurt) and Ralf Willer (M&A, Berlin) as well as associates Oda Goetzke, Marc Seeger, Tianyuan Zhuang, Johannes Fütterer, Benedikt Statz, Alexander von Bernstorff (all Düsseldorf), Yenilee Ičagić (Berlin) (all M&A), Susanne Koch (Life Sciences / Public Law), Julia Fischer, Norman Koschmieder (both Public Law) (all Düsseldorf), Marius Mayer (Employment) and Sebastian Heinrichs (Tax) (both Frankfurt).